Navigation Links
Access Pharmaceuticals Presents new Combination Data on the Company's Angiolix(R) Therapeutic Monoclonal Antibody
Date:1/26/2009

a chemotherapeutic agent that combines multiple modes of action to overcome drug resistance. Access is also developing Phenylbutyrate ("PB"), an HDAC inhibitor and differentiating agent currently a Phase 2 clinical candidate. For additional information on Access Pharmaceuticals, please visit our website at www.accesspharma.com .

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended, and that involve risks and uncertainties. These statements include those relating to: our ability to close the financing transaction, early results from our clinical trial, Access' plans to continue and initiate clinical trials, the value of its products in the market, its ability to achieve clinical and commercial success and its ability to successfully develop marketed products. These statements are subject to numerous risks, including but not limited Access' need to obtain additional financing in order to continue the clinical trial and operations and to the risks detailed in Access' Annual Reports on Form 10-K and other reports filed by Access and MacroChem with the Securities and Exchange Commission.


'/>"/>
SOURCE Access Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Wrist Access Safer, Easier for Many Patients Undergoing Minimally Invasive Treatment of Blocked Heart Arteries
2. Access Pharmaceuticals Presents New Data on the Companys Angiolix(R) Therapeutic Monoclonal Antibody
3. Unprecedented 8th Year Start Up of National Direct AmeriCorps Program Access to Care Through Service (ACTS) Parent, Lead Organization The Philadelphia AIDS Consortium and World Health Care Infrastructures
4. St. Jude Study Gives New Insights Into How Cells Accessorize Their Proteins
5. McGraw-Hill Professional Launches Drug Effectiveness Resource on AccessPharmacy
6. Cell Therapeutics, Inc. (CTI) to Hold Conference Call to Discuss Agreement With Bayer Schering Pharma for Access to Phase III Zevalin(R) FIT Trial Data
7. Access Pharmaceuticals Presents Favorable Ovarian Cancer Data and Clinical Update on ProLindac(TM) Development at Prestigious International Symposium
8. Access Pharmaceuticals Presents New Data on the Companys Cobalamin(TM) Technology at an International Polymer Therapeutics Symposium
9. IDM Pharma Announces Updated Data From Mifamurtide (L-MTP-PE) Compassionate Access Program
10. Roche Gains Access to Important Oncology Target With Potential for Treating Major Cancers Such as Breast and Lung; First Drug Candidate in Phase I Clinical Testing
11. IDM Pharma Announces Availability of Mifamurtide (L-MTP-PE) Through Compassionate Access Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014   Vittamed Corporation , a ... announced today that T. (Teo) Forcht Dagi , ... company,s Board of Directors. " Teo Forcht ... in neurosurgery, medical innovation and venture capital," said Remis ... delighted to add his clinical, strategic, and entrepreneurial expertise to ...
(Date:8/29/2014)... , Aug. 29, 2014 Diseases largely eradicated ... generation ago are returning. Measles was declared eliminated in ... 2014 as of August 15—the highest incidence in 20 ... health department declared whooping cough a problem of ... getting sick and dying from these preventable diseases—in part ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- ChemImage will present a workshop focused on ... Forensic Science Society,s 22 nd International Symposium ... Australia .  Forensic Scientists will be in ... imaging can bring to examination procedures. ... Product Development at ChemImage, will host a workshop ...
Breaking Medicine Technology:Vittamed Adds Prominent Neurosurgeon and Venture Capitalist T. Forcht Dagi to Board of Directors 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 2Vaccines at the Crossroads: Outbreaks On the Rise Across America 3ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... Tengion, Inc. (Nasdaq: TNGN ), a leader in ... as its President and Chief Executive Officer. Most recently, Mr. ... and Chief Executive Officer of CCS Medical, Inc., a company ... services for patients with chronic diseases, from 2008 until completion ...
... Accuray Incorporated (Nasdaq: ARAY ), the premier ... scheduled to present at the Oppenheimer Healthcare Conference in ... 1:00 p.m. EST/10:00 a.m. PST.  A ... from the Investor Relations page of the Company,s website ...
Cached Medicine Technology:Tengion Appoints John L. Miclot President and Chief Executive Officer 2Tengion Appoints John L. Miclot President and Chief Executive Officer 3Tengion Appoints John L. Miclot President and Chief Executive Officer 4
(Date:8/30/2014)... (PRWEB) August 30, 2014 Jake W., 18, ... while in the Back2Basics Outdoor Adventures transition program ... finish high school so I can actually start on a ... and math, and I'm done.” , He has six months ... Back2Basics program. Most clients choose to continue on to the ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 “In 2013, a ... The Jones Firm says in a recently released article on ... person was injured in an auto accident every 12 minutes, ... minutes,” they continue. “Based on the 2013 statistics, between now ... vehicle collision.” , The threat of an auto accident is ...
(Date:8/30/2014)... Miami, FL (PRWEB) August 30, 2014 Zensah®, ... new Camo Compression Leg Sleeve . The camo sleeves ... Compression Leg Sleeve collection. The camo line includes classic ... purple and magenta. , Known as tibial stress syndrome, ... side of the lower leg. Swollen and irritated muscles, stress ...
(Date:8/30/2014)... Barton Associates, an industry leading physician, ... , announces a new office location in Keene, NH, ... headquartered in Peabody, MA, with additional staffing centers in ... Jupiter, FL. , Barton Associates made the decision to ... crisis affecting the United States, a crisis that will ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 What challenges ... What are the latest trends, concerns, and considerations? ... Dr. Ken Pendleton recently spoke with Woody Wommack, Southeast ... of current issues in football recruiting. Notably, Wommack ... younger athletes, changes that he thinks are coming as ...
Breaking Medicine News(10 mins):Health News:Startling Washington Auto Accident Statistics Discussed In Recently Released Article By The Jones Firm 2Health News:Camo Compression Leg Sleeves Provide Shin Splint Relief for Runners 2Health News:Barton Associates to Open a New Office Location in Keene, NH 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 2Health News:Woody Wommack of Rivals.com Discusses the World of NCAA Football Recruiting on SCI TV 3
... by Nancy Speck, PhD, professor of Cell and Developmental ... University of Pennsylvania, has discovered a molecular marker for ... in the developing embryo, which provides much-needed insights for ... in the bone marrow of adult mammals, generate all ...
... populations with a low prevalence of tuberculosis (TB), the ... in the U.S for the diagnosis of TB ... "We compared commercially available tests for latent tuberculosis ... LTBI prevalence," said James Mancuso, MD, DrPH, of the ...
... HealthDay Reporter , THURSDAY, Dec. 8 (HealthDay News) -- ... the known cosmetic and psychological advantages, a new study ... women with DCIS (ductal carcinoma in situ, an early ... Hershman, an associate professor of medicine and epidemiology at ...
... 8 (HealthDay News) -- New guidelines on treating so-called "latent" ... simplify the course of the therapy from about 9 months ... Control and Prevention. The new guidelines for public health ... expert opinion and the results of three clinical trials -- ...
... one of the coauthors of a new paper by a group ... for strong steps to be taken to control the global crisis ... of steps that need to be taken on a global scale ... a meeting the group held at the Banbury Conference Centre in ...
... Ga. A study that may help personalize pain ... at Georgia Health Sciences University. Dr. Cheedy Jaja, ... Nursing, has received a three-year National Institutes of Health ... play a role in metabolizing opioids could help physicians ...
Cached Medicine News:Health News:Penn study unlocks origins of blood stem cells 2Health News:Discordance among commercially-available diagnostics for latent TB infection 2Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 2Health News:Few Women Get Breast Reconstruction After Mastectomy: Study 3Health News:CDC Issues New TB Treatment Guidelines 2Health News:New paper calls for strong steps to tackle antibiotic resistance 2Health News:Study probes genetic link to sickle cell pain management 2Health News:Study probes genetic link to sickle cell pain management 3Health News:Study probes genetic link to sickle cell pain management 4
... Radiation Protection Goggles fit ... be used by the ... leaded glass, 1.0 mm ... provide increased scatter radiation ...
QualCraft™ Euro Lite has a molded nylon frame that fits most faces. Universal keyhole nose bridge fits narrow to average noses. Available with or without lead vinyl-lined side shields....
QualCraft™ Radiation Protection Eyewear providex maximum comfort and eye protection! Lenses made of 0.75 mm leaded glass. Side shields of 0.30 mm leaded acrylic help seal out scatter radiation ...
Qualcraft™ Radiation Readers, Wraparound Glasses. Protect yourself and have close-vision clarity....
Medicine Products: